Technology | February 07, 2011

New Stabilizer and Positioner System Launched

February 7, 2011 – A new positioning system has been launched that is used in performing off- pump coronary artery bypass (OPCAB) procedures on coronary artery bypass graft (CABG) patients. The Acrobat-i Stabilizer and Positioner System, by Maquet Cardiovascular, has a significantly lower profile design and tubing management features that allow increased access to and visibility of the surgical field.

It features a 180-degree side-to-side range of motion and has the ability to vertically drop into the chest cavity. Also, its maneuverability and arm strength help cardiovascular surgeons gain better access and control for hard-to-reach vessels during CABG surgery.

"With the new design of the arm for the Acrobat-i Stabilizer, visualization during Off-Pump Cardiovascular Bypass surgery is much improved,” said Reza Khalafi, M.D., Plaza Medical Center, Fort Worth, Texas. “This is especially noticeable for creating anastomoses on the lateral wall and back side of the heart, making the OPCAB procedure easier to perform.”

In a CABG procedure, a healthy blood vessel, such as the saphenous vein, from the leg, or the radial artery, from the arm, is used to bypass a blockage in the heart. The vessel anastomoses is done during OPCAB, also called “beating heart” surgery, which is performed without the use of cardiopulmonary bypass, also known as a “heart-lung machine.”

Studies have shown that OPCAB reduces patient mortality, improves post-surgery neurological outcomes and shortens recovery times compared with on-pump surgery.

"The new Acrobat-i system enabled me to see and do more during CABG performed on a beating heart,” said Marc Katz, M.D., St. Mary's Hospital in Richmond, Va. “The Acrobat-i System will help me reach and stabilize hard-to-visualize vessels on OPCAB cases."

For more information: www.maquet.com

Related Content

SherpaPak Cardiac Transport System Cleared for Pediatric and Small Donor Hearts
Technology | Cardiovascular Surgery | February 01, 2019
Paragonix Technologies Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) for a design...
Transplanting Pig Hearts Into Humans One Step Closer. A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

A pig heart, shown here, is very similar in size and anatomy to a human heart. For this reason, pigs are used extensively in pre-clinical animal testing for new implantable cardiovascular devices. If pig hearts could be used for human transplantation, it would greatly alleviate shortages of donor human hearts.

News | Cardiovascular Surgery | December 11, 2018
The scientific journal Nature recently published an article from Munich University Hospital which describes the long-...
Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Overlay Init